Month: September 2023

SAFETY HARBOR, Florida, Sept. 07, 2023 (GLOBE NEWSWIRE) — Eightco Holdings Inc. (NASDAQ: OCTO) (“Eightco” or the “Company”) announced today it will be presenting at the H.C. Wainwright 25th Annual Global Investment Conference, held September 11-13, 2023, at the Lotte New York Palace Hotel in New York City. The Company’s leadership team, including CEO Brian McFadden and CFO Brett Vroman, along with other key executives, will be in attendance during the presentation and will be available for one-on-one meetings throughout the conference. This conference serves as an excellent platform for Eightco to engage with the investor community and discuss various facets of our business. We look forward to sharing insights into our recent achievements, ongoing developments, and our strategic vision for the future. Brian McFadden, CEO of Eightco...

OSB GROUP PLC7 September 2023 LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC£3 BILLION EURO MEDIUM TERM NOTE PROGRAMMEPUBLICATION OF FINAL TERMS – SERIES 2023-2 The following final terms (the “Final Terms”) are available for viewing: Issue of GBP 300,000,000 Fixed Rate Resetting Notes due 7 September 2028 (ISINXS2642668821) (Series 2023-2) (the “Notes”) under the £3 billion Euro Medium Term Note programme of OSB GROUP PLC (the “Programme”). Please read the disclaimer below “Disclaimer – Intended Addressees” before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below. To view the Final Terms, paste the following URL into the address bar of your browser: https://www.osb.co.uk/investors/debt-investors/emtn-programme/ A copy of the Final Terms has been submitted...

TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital” and “Company”), a leading provider of flexible growth capital and alternative debt solutions, is pleased to announce that it has completed a second tranche of its previously disclosed non-convertible loan transaction in the principal amount of C$3.015 million (the “Loans”). The Loans will be evidenced by unsecured, non-convertible debentures (the “Debentures”) issued by the Company to the Lenders pursuant to the terms of a debenture indenture entered between the Company and Olympia Trust Company, as debenture trustee. The Company closed an initial tranche of loans on August 1, 2023 with lenders advancing an aggregate amount of C$17.9 million. Additional details regarding the terms of the Loans can be found in the Company’s press release...

Conductor Targets Beneath Layden Intrusive at Taylor Brook ProjectConductor Targets Beneath Layden Intrusive at Taylor Brook ProjectTORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to announce results from its Hybrid Controlled Source Audio-Magnetotelluric (“Hybrid CSAMT”) survey carried out over the Layden Intrusive at Taylor Brook. The data suggests that multiple large conductor targets are present beneath Layden, hosted by similar and related magmatic rocks, below all drilling to date. Sizes of the conductor targets are significant, ranging up to several hundred metres long by >100m wide by >100m thick. Paul Sobie, CEO of Churchill stated, “The Hybrid CSAMT survey has proven successful at allowing us to see beneath Layden, and critically in identifying...

Infographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4Infographic 5Infographic 5Drill Highlights:GD-23-197 drilled from Pad 16 intersected 3 sulphide-rich mineralized shear zones that include the Surebet Zone, Bonanza Shear and a new highly mineralized horizon within the Hazelton Volcanics located only 20 meters below the Bonanza Shear named the Golden Gate Zone, demonstrating the presence of at least 3 stacked and significantly mineralized shear zones outcropping that remain open. (see model and images below).A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4f49c03b-5cda-4077-9bba-f9c8b057d1a1The Golden Gate Zone is believed to be the fluid pathway proximal to the Surebet Zone...

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced presentations of data from its CNS portfolio at the 2023 U.S. Psych Congress, being held in Nashville, Tenn. from September 6-10. The presentations demonstrate the Company’s commitment to continued innovation to address unmet needs in difficult-to-treat CNS disorders. “Axsome’s presentations at Psych Congress highlight our commitment to advancing research of medicines that have the potential to improve the...

Zilebesiran met primary endpoint demonstrating greater than 15 mmHg reduction of systolic blood pressure at three months of treatment compared to placebo Study met key secondary endpoints showing consistent and sustained reductions of systolic blood pressure at six months Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension Full study results to be presented at an upcoming scientific conferenceBasel, 7 September 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam announced today that the Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT), met the primary endpoint. Zilebesiran demonstrated a clinically significant reduction in 24-hour mean systolic blood pressure (SBP) at month three,...

Oxford Biomedica to host webinar showcasing the TetraVectaTM system Oxford, UK – 07 September 2023: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a quality and innovation-led viral vector CDMO, today announces that it will host a webinar on the TetraVectaTM system, the Company’s 4th generation lentiviral vector delivery system, on Monday 2 October 2023. The webinar titled “4th Generation Lentiviral Vectors: An Improved Gene Delivery System” will feature presentations by Dr Nick Clarkson, Vice President, Head of Platform Research at Oxford Biomedica and Dr Dan Farley, Senior Director of the Vector Engineering Group at Oxford Biomedica, who will discuss how the TetraVecta™ system can significantly enhance the development and manufacturing of safer and more effective lentiviral vector-based therapies through...

Dr. Alice Tomei of the University of Miami, Miller School of Medicine, to present updates in podium presentation at the 2023 IPITA-IXA-CTRMS Joint Congress being held in San Diego from October 26-29 LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 07, 2023 (GLOBE NEWSWIRE) — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today provided a development update on its exclusively licensed, proprietary conformal coating immune protection technology, being advanced in combination with the Cell Pouch™ through a collaboration with Dr. Alice Tomei at the University of Miami, Miller School of Medicine. The goal of the technology is to eliminate the need for long-term use of conventional immunosuppressive medications currently required to prevent graft rejection with...

Higher lithium purity with lower leach temperature indicates enhanced economic potential VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | NASDAQ:AMLI | Frankfurt:5LA1) is pleased to announce results of on-going process work on TLC claystones aimed at continued improvement and optimization of all phases of the chemical process to produce lithium carbonate (“LC”). Optimization work focused on leaching conditions and lithium recovery, minimizing lithium losses during neutralization and magnesium sulphate crystallization, and on increasing the LC purity in the precipitation stage. Highlights:LC purity increased to 99.59% (up from 99.4%) Lower leach temperature of 50°C (down from 90°C), with continued high lithium extraction rates (95%); Significant...